Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/03/2020 ,inter alia, to consider and approve Notice is hereby given that pursuant to Regulation 25 of SEBI (Listing obligation and Disclosure Requirement) Regulation, 2015 and Schedule IV, Clause VII of companies act, 2013 that a separate meeting of the Independent Directors of the Company will be held on Saturday, 14th March 2020 at 01: 00 noon at the registered office of the Company to transact the following business:

1) To review the performance of non- independent directors and the Board as a whole.

2) To review the performance of the chairperson of the company, taking into account the views of executive directors and non-executive directors.

3) To Evaluated the Quantity, Quality and timeliness of flow of information between the Company management and Board in line with the requirement of Regulation 25 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with applicable provisions of Schedule IV of the Companies Act, 2013.

4) Any other business with the permission of the chair.